Granulocyte Colony-Stimulating Factor in the Treatment of High-Risk Febrile Neutropenia: a Multicenter Randomized Trial
Rocio García‐Carbonero(Hospital Universitario 12 De Octubre), L. Paz-Ares(Marqués de Valdecilla University Hospital), F. Ribera(Marqués de Valdecilla University Hospital), Alfonso Yubero(Marqués de Valdecilla University Hospital), Alberto Arcediano(Marqués de Valdecilla University Hospital), V. Guillem(Marqués de Valdecilla University Hospital), Charlyn Gomez(Marqués de Valdecilla University Hospital), Javier Hornedo(Marqués de Valdecilla University Hospital), José Luis Perez‐Gracia(Clinica Universidad de Navarra), A. Rueda(Marqués de Valdecilla University Hospital), M. López-Brea(Marqués de Valdecilla University Hospital), María Victoria Tornamira(Marqués de Valdecilla University Hospital), A. Trés(Universidad de Zaragoza), Carlos Lumbreras(Marqués de Valdecilla University Hospital), H. Cortés-Funes(Centre Hospitalier René-Dubos), José Mayordomo(Royal Bournemouth Hospital)
Cited by 179
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|2.2k
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
|UCL Discovery (University College London)|1997|1k